Skip to main content
SpringerLink
Log in

Neurocysticercosis and Other CNS Helminthic Infections

  • Chapter
  • First Online:
Neurological Complications of Infectious Diseases

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Helminth infections are common worldwide and include infections with roundworms (nematodes) and flatworms (cestodes and trematodes). Infections of the central nervous system (CNS) can be caused by a wide range of helminths. As a group, they are common in resource-limited countries, but are rare in wealthy countries. Among these infections, neurocysticercosis is an important cause of seizures worldwide and also a cause of hydrocephalus. Angiostrongylus, Baylisascaris, Toxocara, and Gnathostoma among others can cause eosinophilic meningitis. In this chapter we review epidemiology, presentation, diagnosis, treatment and prevention of the common helminthic infections including infections caused by cestodes, nematodes and trematodes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J. Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology. 2006;67(12):2135–9.

    Article  CAS  PubMed  Google Scholar 

  2. Moyano LM, Saito M, Montano SM, Gonzalvez G, Olaya S, Ayvar V, et al. Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru. PLoS Negl Trop Dis. 2014;8(2):e2692.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Debacq G, Moyano LM, Garcia HH, Boumediene F, Marin B, Ngoungou EB, et al. Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy. PLoS Negl Trop Dis. 2017;11(3):e0005153.

    Article  PubMed  PubMed Central  Google Scholar 

  4. O’Neal SE, Flecker RH. Hospitalization frequency and charges for neurocysticercosis, United States, 2003–2012. Emerg Infect Dis. 2015;21(6):969–76.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. O’Keefe KA, Eberhard ML, Shafir SC, Wilkins P, Ash LR, Sorvillo FJ. Cysticercosis-related hospitalizations in the United States, 1998–2011. Am J Trop Med Hyg. 2015;92(2):354–9.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Flecker RH, O’Neal SE, Townes JM. Evaluating healthcare claims for neurocysticercosis by using all-payer all-claims data, Oregon, 2010–2013. Emerg Infect Dis. 2016;22(12):2168–70.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis. 2002;8(6):608–13.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Restrepo BI, Llaguno P, Sandoval MA, Enciso JA, Teale JM. Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2. J Neuroimmunol. 1998;89(1–2):64–72.

    Article  CAS  PubMed  Google Scholar 

  9. Restrepo BI, Alvarez JI, Castano JA, Arias LF, Restrepo M, Trujillo J, et al. Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect Immun. 2001;69(7):4554–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13(12):1202–15.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kramer LD, Locke GE, Byrd SE, Daryabagi J. Cerebral cysticercosis: documentation of natural history with CT. Radiology. 1989;171(2):459–62.

    Article  CAS  PubMed  Google Scholar 

  12. Dumas JL, Visy JM, Belin C, Gaston A, Goldlust D, Dumas M. Parenchymal neurocysticercosis: follow-up and staging by MRI. Neuroradiology. 1997;39(1):12–8.

    Article  CAS  PubMed  Google Scholar 

  13. Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, et al. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol. 2008;7(12):1099–105.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Gupta RK, Awasthi R, Rathore RK, Verma A, Sahoo P, Paliwal VK, et al. Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI. Neurology. 2012;78(9):618–25.

    Article  CAS  PubMed  Google Scholar 

  15. Nash TE, Ware JM, Mahanty S. Natural history of patients with perilesional edema around Taenia solium calcified granulomas. J Infect Dis. 2017;215(7):1141–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Robinson P, Garza A, Weinstock J, Serpa JA, Goodman JC, Eckols KT, et al. Substance P causes seizures in neurocysticercosis. PLoS Pathog. 2012;8(2):e1002489.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Nash TE, Bartelt LA, Korpe PS, Lopes B, Houpt ER. Calcified neurocysticercus, perilesional edema, and histologic inflammation. Am J Trop Med Hyg. 2014;90(2):318–21.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Singhi P, Malhi P, Suthar R, Deo B, Khandelwal NK. Long-term cognitive outcome of children with parenchymal neurocysticercosis: a prospective observation study. J Child Neurol. 2018;33(7):468–73.

    Article  PubMed  Google Scholar 

  19. Garcia HH, Gonzalez AE, Rodriguez S, Tsang VC, Pretell EJ, Gonzales I, et al. Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology. 2010;75(7):654–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Serpa JA, Graviss EA, Kass JS, White AC Jr. Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore). 2011;90(1):81–6.

    Article  Google Scholar 

  21. Webb CM, White AC Jr. Update on the diagnosis and management of neurocysticercosis. Curr Infect Dis Rep. 2016;18(12):44.

    Article  PubMed  Google Scholar 

  22. Del Brutto OH, Arroyo G, Del Brutto VJ, Zambrano M, Garcia HH. On the relationship between calcified neurocysticercosis and epilepsy in an endemic village: a large-scale, computed tomography-based population study in rural Ecuador. Epilepsia. 2017;58(11):1955–61.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Moyano LM, O’Neal SE, Ayvar V, Gonzalvez G, Gamboa R, Vilchez P, et al. High prevalence of asymptomatic neurocysticercosis in an endemic rural community in Peru. PLoS Negl Trop Dis. 2016;10(12):e0005130.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Del Brutto OH, Issa NP, Salgado P, Del Brutto VJ, Zambrano M, Lama J, et al. The association between neurocysticercosis and hippocampal atrophy is related to age. Am J Trop Med Hyg. 2017;96(1):243–8.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Qavi A, Garg RK, Malhotra HS, Jain A, Kumar N, Malhotra KP, et al. Disseminated cysticercosis: clinical spectrum, toll-like receptor-4 gene polymorphisms and role of albendazole: a prospective follow-up of 60 cases with a review of 56 published cases. Medicine (Baltimore). 2016;95(39):e4882.

    Article  CAS  Google Scholar 

  26. Rangel-Castilla L, Serpa JA, Gopinath SP, Graviss EA, Diaz-Marchan P, White AC Jr. Contemporary neurosurgical approaches to neurocysticercosis. Am J Trop Med Hyg. 2009;80(3):373–8.

    Article  PubMed  Google Scholar 

  27. Torres-Corzo J, Rodriguez-della Vecchia R, Rangel-Castilla L. Bruns syndrome caused by intraventricular neurocysticercosis treated using flexible endoscopy. J Neurosurg. 2006;104(5):746–8.

    Article  PubMed  Google Scholar 

  28. Marcin Sierra M, Arroyo M, Cadena Torres M, Ramirez Cruz N, Garcia Hernandez F, Taboada D, et al. Extraparenchymal neurocysticercosis: demographic, clinicoradiological, and inflammatory features. PLoS Negl Trop Dis. 2017;11(6):e0005646.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Callacondo D, Garcia HH, Gonzales I, Escalante D, Nash TE. High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis. Neurology. 2012;78(18):1394–400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Alsina GA, Johnson JP, McBride DQ, Rhoten PR, Mehringer CM, Stokes JK. Spinal neurocysticercosis. Neurosurg Focus. 2002;12(6):e8.

    Article  PubMed  Google Scholar 

  31. Pushker N, Bajaj MS, Chandra M, Neena. Ocular and orbital cysticercosis. Acta Ophthalmol Scand. 2001;79(4):408–13.

    Article  CAS  PubMed  Google Scholar 

  32. Rath S, Honavar SG, Naik M, Anand R, Agarwal B, Krishnaiah S, et al. Orbital cysticercosis: clinical manifestations, diagnosis, management, and outcome. Ophthalmology. 2010;117(3):600–5, 5.e1.

    Article  Google Scholar 

  33. White AC, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, et al. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg. 2018;98(4):945–66.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bustos JA, Garcia HH, Del Brutto OH. Reliability of diagnostic criteria for neurocysticercosis for patients with ventricular cystic lesions or granulomas: a systematic review. Am J Trop Med Hyg. 2017;97(3):653–7.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Del Brutto OH, Nash TE, White AC Jr, Rajshekhar V, Wilkins PP, Singh G, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2017;372:202–10.

    Article  PubMed  Google Scholar 

  36. Sharma T, Sinha S, Shah N, Gopal L, Shanmugam MP, Bhende P, et al. Intraocular cysticercosis: clinical characteristics and visual outcome after vitreoretinal surgery. Ophthalmology. 2003;110(5):996–1004.

    Article  PubMed  Google Scholar 

  37. Lerner A, Shiroishi MS, Zee CS, Law M, Go JL. Imaging of neurocysticercosis. Neuroimaging Clin N Am. 2012;22(4):659–76.

    Article  PubMed  Google Scholar 

  38. do Amaral LL, Ferreira RM, da Rocha AJ, Ferreira NP. Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top Magn Reson Imaging. 2005;16(2):127–44.

    Article  PubMed  Google Scholar 

  39. Carrillo Mezo R, Lara Garcia J, Arroyo M, Fleury A. Relevance of 3D magnetic resonance imaging sequences in diagnosing basal subarachnoid neurocysticercosis. Acta Trop. 2015;152:60–5.

    Article  PubMed  Google Scholar 

  40. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis. 1989;159(1):50–9.

    Article  CAS  PubMed  Google Scholar 

  41. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis. 1991;164(5):1007–9.

    Article  CAS  PubMed  Google Scholar 

  42. Garcia HH, Gilman RH, Catacora M, Verastegui M, Gonzalez AE, Tsang VC. Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru. J Infect Dis. 1997;175(2):486–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Gonzalez AE, Bustos JA, Garcia HH, Rodriguez S, Zimic M, Castillo Y, et al. Successful antiparasitic treatment for cysticercosis is associated with a fast and marked reduction of circulating antigen levels in a naturally infected pig model. Am J Trop Med Hyg. 2015;93(6):1305–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. White AC Jr, Garcia HH. Updates on the management of neurocysticercosis. Curr Opin Infect Dis. 2018;31(5):377–82.

    Article  PubMed  Google Scholar 

  45. Bustos JA, Garcia HH, Del Brutto OH. Antiepileptic drug therapy and recommendations for withdrawal in patients with seizures and epilepsy due to neurocysticercosis. Expert Rev Neurother. 2016;16(9):1079–85.

    Article  CAS  PubMed  Google Scholar 

  46. Garcia HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev. 2002;15(4):747–56.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Zhao BC, Jiang HY, Ma WY, Jin DD, Li HM, Lu H, et al. Albendazole and corticosteroids for the treatment of solitary cysticercus granuloma: a network meta-analysis. PLoS Negl Trop Dis. 2016;10(2):e0004418.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350(3):249–58.

    Article  CAS  PubMed  Google Scholar 

  49. Romo ML, Wyka K, Carpio A, Leslie D, Andrews H, Bagiella E, et al. The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. Trans R Soc Trop Med Hyg. 2015;109(11):738–46.

    Article  CAS  PubMed  Google Scholar 

  50. Garcia HH, Lescano AG, Gonzales I, Bustos JA, Pretell EJ, Horton J, et al. Cysticidal efficacy of combined treatment with praziquantel and albendazole for parenchymal brain cysticercosis. Clin Infect Dis. 2016;62(11):1375–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Garcia HH, Gonzales I, Lescano AG, Bustos JA, Zimic M, Escalante D, et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014;14(8):687–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Mejia R, Nash TE. Corticosteroid withdrawal precipitates perilesional edema around calcified Taenia solium cysts. Am J Trop Med Hyg. 2013;89(5):919–23.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Garcia HH, Gonzales I, Lescano AG, Bustos JA, Pretell EJ, Saavedra H, et al. Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after. Epilepsia. 2014;55(9):1452–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Proano JV, Torres-Corzo J, Rodriguez-Della Vecchia R, Guizar-Sahagun G, Rangel-Castilla L. Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery. Childs Nerv Syst. 2009;25(11):1467–75.

    Article  PubMed  Google Scholar 

  55. Chen G, Xiao Q, Zheng J, Wu J, Ao Q, Liu Y. Endoscopic transaqueductal removal of fourth ventricular neurocysticercosis: report of three cases. Turk Neurosurg. 2015;25(3):488–92.

    PubMed  Google Scholar 

  56. Kaif M, Husain M, Ojha BK. Endoscopic management of intraventricular neurocysticercosis. Turk Neurosurg. 2019;29(1):59–65.

    PubMed  Google Scholar 

  57. Nash TE, Ware JM, Mahanty S. Intraventricular neurocysticercosis: experience and long-term outcome from a tertiary referral center in the United States. Am J Trop Med Hyg. 2018;98(6):1755–62.

    Article  PubMed  PubMed Central  Google Scholar 

  58. White AC. Controlling the host response in neurocysticercosis. Am J Trop Med Hyg. 2019;100(3):483–4.

    Article  PubMed  Google Scholar 

  59. Nash TE, Ware JM, Coyle CM, Mahanty S. Etanercept to control inflammation in the treatment of complicated neurocysticercosis. Am J Trop Med Hyg. 2019;100(3):609–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Okello AL, Thomas L, Inthavong P, Ash A, Khamlome B, Keokamphet C, et al. Assessing the impact of a joint human-porcine intervention package for Taenia solium control: results of a pilot study from northern Lao PDR. Acta Trop. 2016;159:185–91.

    Article  PubMed  Google Scholar 

  61. Garcia HH, Gonzalez AE, Tsang VC, O’Neal SE, Llanos-Zavalaga F, Gonzalvez G, et al. Elimination of Taenia solium transmission in Northern Peru. N Engl J Med. 2016;374(24):2335–44.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Kern P, Menezes da Silva A, Akhan O, Müllhaupt B, Vizcaychipi KA, Budke C, et al. The Echinococcoses: diagnosis, clinical management and burden of disease. Adv Parasitol. 2017;96:259–369.

    Article  CAS  PubMed  Google Scholar 

  63. Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, et al. Echinococcosis: advances in the 21st century. Clin Microbiol Rev. 2019;32(2):e00075–18.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Brunetti E, Kern P, Vuitton DA, WHO-IWGE WPft. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114(1):1–16.

    Article  PubMed  Google Scholar 

  65. Luo K, Luo DH, Zhang TR, Wen H. Primary intracranial and spinal hydatidosis: a retrospective study of 21 cases. Pathog Glob Health. 2013;107(2):47–51.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Altinörs N, Bavbek M, Caner HH, Erdogan B. Central nervous system hydatidosis in Turkey: a cooperative study and literature survey analysis of 458 cases. J Neurosurg. 2000;93(1):1–8.

    Article  PubMed  Google Scholar 

  67. Stojkovic M, Junghanss T. Cystic and alveolar echinococcosis. Handb Clin Neurol. 2013;114:327–34.

    Article  PubMed  Google Scholar 

  68. Luo X, Jedlicka SS, Jellison KL. Role of wall shear stress in Cryptosporidium parvum Oocyst attachment to environmental biofilms. Appl Environ Microbiol. 2017;83(24):e01533–17.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Mohindra S, Savardekar A, Gupta R, Tripathi M, Rane S. Varied types of intracranial hydatid cysts: radiological features and management techniques. Acta Neurochir. 2012;154(1):165–72.

    Article  PubMed  Google Scholar 

  70. Pagnozzi D, Addis MF, Biosa G, Roggio AM, Tedde V, Mariconti M, et al. Diagnostic accuracy of antigen 5-based ELISAs for human cystic echinococcosis. PLoS Negl Trop Dis. 2016;10:e0004585.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  71. Vidhate MR, Singh D, Sharma P, Singh MK. Cerebral hydatid cyst showing pathognomonic daughter cysts. Ann Indian Acad Neurol. 2011;14:217–8.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Kim JG, Ahn CS, Sohn WM, Nawa Y, Kong Y. Human sparganosis in Korea. J Korean Med Sci. 2018;33(44):e273.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Liu Q, Li MW, Wang ZD, Zhao GH, Zhu XQ. Human sparganosis, a neglected food borne zoonosis. Lancet Infect Dis. 2015;15(10):1226–35.

    Article  PubMed  Google Scholar 

  74. Hong D, Xie H, Wan H, An N, Xu C, Zhang J. Efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: a multicenter retrospective cohort study. PLoS Negl Trop Dis. 2018;12(10):e0006918.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Liao H, Li D, Zhou B, Liu J, Li Y, Liu H, et al. Imaging characteristics of cerebral sparganosis with live worms. J Neuroradiol. 2016;43(6):378–83.

    Article  PubMed  Google Scholar 

  76. Yu Y, Shen J, Yuan Z, Xia Z, Gao F, Jiang L, et al. Cerebral sparganosis in children: epidemiologic and radiologic characteristics and treatment outcomes: a report of 9 cases. World Neurosurg. 2016;89:153–8.

    Article  PubMed  Google Scholar 

  77. Zhang P, Zou Y, Yu FX, Wang Z, Lv H, Liu XH, et al. Follow-up study of high-dose praziquantel therapy for cerebral sparganosis. PLoS Negl Trop Dis. 2019;13(1):e0007018.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Barratt J, Chan D, Sandaradura I, Malik R, Spielman D, Lee R, et al. Angiostrongylus cantonensis: a review of its distribution, molecular biology and clinical significance as a human pathogen. Parasitology. 2016;143(9):1087–118.

    Article  PubMed  Google Scholar 

  79. Wang QP, Lai DH, Zhu XQ, Chen XG, Lun ZR. Human angiostrongyliasis. Lancet Infect Dis. 2008;8(10):621–30.

    Article  PubMed  Google Scholar 

  80. Ansdell V, Wattanagoon Y. Angiostrongylus cantonensis in travelers: clinical manifestations, diagnosis, and treatment. Curr Opin Infect Dis. 2018;31(5):399–408.

    Article  PubMed  Google Scholar 

  81. McAuliffe L, Fortin Ensign S, Larson D, Bavaro M, Yetto J, Cathey M, et al. Severe CNS angiostrongyliasis in a young marine: a case report and literature review. Lancet Infect Dis. 2019; 19(4): e132–e142.

    Google Scholar 

  82. Liu EW, Schwartz BS, Hysmith ND, DeVincenzo JP, Larson DT, Maves RC, et al. Rat lungworm infection associated with central nervous system disease – eight U.S. states, January 2011–January 2017. MMWR Morb Mortal Wkly Rep. 2018;67(30):825–8.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Clinical Subcommittee of the Hawaii Governor's Joint Task Force on Rat Lungworm Disease. Aug 29, 2018.

    Google Scholar 

  84. Martins YC, Tanowitz HB, Kazacos KR. Central nervous system manifestations of Angiostrongylus cantonensis infection. Acta Trop. 2015;141(Pt A):46–53.

    Article  PubMed  Google Scholar 

  85. Jitpimolmard S, Sawanyawisuth K, Morakote N, Vejjajiva A, Puntumetakul M, Sanchaisuriya K, et al. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis. Parasitol Res. 2007;100(6):1293–6.

    Article  PubMed  Google Scholar 

  86. Foster CE, Nicholson EG, Chun AC, Gharfeh M, Anvari S, Seeborg FO, et al. Angiostrongylus cantonensis infection: a cause of fever of unknown origin in pediatric patients. Clin Infect Dis. 2016;63(11):1475–8.

    Article  PubMed  Google Scholar 

  87. Katchanov J, Sawanyawisuth K, Chotmongkol V, Nawa Y. Neurognathostomiasis, a neglected parasitosis of the central nervous system. Emerg Infect Dis. 2011;17:1174–80.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Dzikowiec M, Goralska K, Blaszkowska J. Neuroinvasions caused by parasites. Ann Parasitol. 2017;63(4):243–53.

    PubMed  Google Scholar 

  89. Herman JS, Chiodini PL. Gnathostomiasis, another emerging imported disease. Clin Microbiol Rev. 2009;22:484–92.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Sawanyawisuth K, Chlebicki MP, Pratt E, Kanpittaya J, Intapan PM. Sequential imaging studies of cerebral gnathostomiasis with subdural hemorrhage as its complication. Trans R Soc Trop Med Hyg. 2009;103(1):102–4.

    Article  PubMed  Google Scholar 

  91. Kanpittaya J, Sawanyawisuth K, Intapan PM, Khotsri P, Chotmongkol V, Maleewong W. A comparative study of neuroimaging features between human neuro-gnathostomiasis and angiostrongyliasis. Neurol Sci. 2012;33(4):893–8.

    Article  PubMed  Google Scholar 

  92. Rostami A, Gamble HR, Dupouy-Camet J, Khazan H, Bruschi F. Meat sources of infection for outbreaks of human trichinellosis. Food Microbiol. 2017;64:65–71.

    Article  PubMed  Google Scholar 

  93. Gottstein B, Pozio E, Nöckler K. Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin Microbiol Rev. 2009;22(1):127–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Neghina R, Neghina AM, Marincu I, Iacobiciu I. Reviews on trichinellosis (II): neurological involvement. Foodborne Pathog Dis. 2011;8(5):579–85.

    Article  PubMed  Google Scholar 

  95. Taher EE, Meabed EMH, El Akkad DMH, Kamel NO, Sabry MA. Modified dot-ELISA for diagnosis of human trichinellosis. Exp Parasitol. 2017;177:40–6.

    Article  CAS  PubMed  Google Scholar 

  96. Faber M, Schink S, Mayer-Scholl A, Ziesch C, Schönfelder R, Wichmann-Schauer H, et al. Outbreak of trichinellosis due to wild boar meat and evaluation of the effectiveness of post exposure prophylaxis, Germany, 2013. Clin Infect Dis. 2015;60(12):e98–e104.

    Article  CAS  PubMed  Google Scholar 

  97. Krolewiecki A, Nutman TB. Strongyloidiasis: a neglected tropical disease. Infect Dis Clin N Am. 2019;33(1):135–51.

    Article  Google Scholar 

  98. Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7(7):e2288.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Woll F, Gotuzzo E, Montes M. Strongyloides stercoralis infection complicating the central nervous system. Handb Clin Neurol. 2013;114:229–34.

    Article  PubMed  Google Scholar 

  100. Montes M, Sawhney C, Barros N. Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis. 2010;23(5):500–4.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Formenti F, La Marca G, Perandin F, Pajola B, Romano M, Santucci B, et al. A diagnostic study comparing conventional and real-time PCR for Strongyloides stercoralis on urine and on faecal samples. Acta Trop. 2019;190:284–7.

    Article  CAS  PubMed  Google Scholar 

  102. Buonfrate D, Requena-Mendez A, Angheben A, Cinquini M, Cruciani M, Fittipaldo A, et al. Accuracy of molecular biology techniques for the diagnosis of Strongyloides stercoralis infection-a systematic review and meta-analysis. PLoS Negl Trop Dis. 2018;12(2):e0006229.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  103. Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC Jr, Terashima A, Samalvides F, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016;18(1):Cd007745.

    Google Scholar 

  104. Ma G, Holland CV, Wang T, Hofmann A, Fan CK, Maizels RM, et al. Human toxocariasis. Lancet Infect Dis. 2018;18(1):e14–24.

    Article  PubMed  Google Scholar 

  105. Moreira GM, Telmo Pde L, Mendonca M, Moreira AN, McBride AJ, Scaini CJ, et al. Human toxocariasis: current advances in diagnostics, treatment, and interventions. Trends Parasitol. 2014;30(9):456–64.

    Article  PubMed  Google Scholar 

  106. Deshayes S, Bonhomme J, de La Blanchardiere A. Neurotoxocariasis: a systematic literature review. Infection. 2016;44(5):565–74.

    Article  CAS  PubMed  Google Scholar 

  107. Sánchez SS, García HH, Nicoletti A. Clinical and magnetic resonance imaging findings of neurotoxocariasis. Front Neurol. 2018;9:53.

    Article  PubMed  PubMed Central  Google Scholar 

  108. LMD S, Magalhaes CG, Telmo PL, Cerqueira MP, Donassolo RA, FPL L, et al. Sensitivity and specificity of recombinant proteins in Toxocara spp. for serodiagnosis in humans: differences in adult and child populations. PLoS ONE. 2018;13(12):e0208991.

    Article  CAS  Google Scholar 

  109. Kazacos KR, Jelicks LA, Tanowitz HB. Baylisascaris larva migrans. Handb Clin Neurol. 2013;114:251–62.

    Article  PubMed  Google Scholar 

  110. Graeff-Teixeira C, Morassutti AL, Kazacos KR. Update on baylisascariasis, a highly pathogenic zoonotic infection. Clin Microbiol Rev. 2016;29(2):375–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Rascoe LN, Santamaria C, Handali S, Dangoudoubiyam S, Kazacos KR, Wilkins PP, et al. Interlaboratory optimization and evaluation of a serological assay for diagnosis of human baylisascariasis. Clin Vaccine Immunol. 2013;20(11):1758–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Sircar AD, Abanyie F, Blumberg D, Chin-Hong P, Coulter KS, Cunningham D, et al. Raccoon roundworm infection associated with central nervous system disease and ocular disease – six states, 2013–2015. MMWR Morb Mortal Wkly Rep. 2016;65(35):930–3.

    Article  PubMed  Google Scholar 

  113. Peters JM, Madhavan VL, Kazacos KR, Husson RN, Dangoudoubiyam S, Soul JS. Good outcome with early empiric treatment of neural larva migrans due to baylisascaris procyonis. Pediatrics. 2012;129(3):e806–11.

    Article  PubMed  Google Scholar 

  114. Weerakoon KG, Gobert GN, Cai P, McManus DP. Advances in the diagnosis of human schistosomiasis. Clin Microbiol Rev. 2015;28(4):939–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Ross AG, McManus DP, Farrar J, Hunstman RJ, Gray DJ, Li YS. Neuroschistosomiasis. J Neurol. 2012;259(1):22–32.

    Article  PubMed  Google Scholar 

  116. Ferrari TC, Moreira PR. Neuroschistosomiasis: clinical symptoms and pathogenesis. Lancet Neurol. 2011;10(9):853–64.

    Article  PubMed  Google Scholar 

  117. Coyle CM. Schistosomiasis of the nervous system. Handb Clin Neurol. 2013;114:271–81.

    Article  PubMed  Google Scholar 

  118. Liu H, Lim CC, Feng X, Yao Z, Chen Y, Sun H, et al. MRI in cerebral schistosomiasis: characteristic nodular enhancement in 33 patients. AJR Am J Roentgenol. 2008;191(2):582–8.

    Article  PubMed  Google Scholar 

  119. Furst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(3):210–21.

    Article  PubMed  Google Scholar 

  120. Zhang XL, Wang Y, Wang GX, Chen WB, He X, Niu H, et al. Distribution and clinical features of paragonimiasis skrjabini in three gorges reservoir region. Parasitol Int. 2012;61(4):645–9.

    Article  PubMed  Google Scholar 

  121. Chen J, Chen Z, Lin J, Zhu G, Meng H, Cui G, et al. Cerebral paragonimiasis: a retrospective analysis of 89 cases. Clin Neurol Neurosurg. 2013;115(5):546–51.

    Article  PubMed  Google Scholar 

  122. Calvopina M, Romero-Alvarez D, Macias R, Sugiyama H. Severe pleuropulmonary paragonimiasis caused by paragonimus mexicanus treated as tuberculosis in Ecuador. Am J Trop Med Hyg. 2017;96(1):97–9.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Lane MA, Marcos LA, Onen NF, Demertzis LM, Hayes EV, Davila SZ, et al. Paragonimus kellicotti Flukes in Missouri, USA. Emerg Infect Dis. 2012;18(8):1263–7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA

    M. B. Tanabe

  2. Department of Medicine, University of Texas Medical Branch, Galveston, TX, USA

    M. Schilling

  3. Department of Internal Medicine, Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA

    A. C. White Jr.

Authors
  1. M. B. Tanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Schilling
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. C. White Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. B. Tanabe .

Editor information

Editors and Affiliations

  1. UT Health McGovern Medical School, Houston, TX, USA

    Rodrigo Hasbun, MD MPH

  2. Div of Infectious Dis, MCN A-2200, Vanderbilt University, Nashville, TN, USA

    Karen C. Bloch, MD MPH

  3. Dept of Infectious Diseases, Apt 635, Cleveland Clinic Foundation, Cleveland, OH, USA

    Adarsh Bhimraj, MD

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tanabe, M.B., Schilling, M., White, A.C. (2021). Neurocysticercosis and Other CNS Helminthic Infections. In: Hasbun, MD MPH, R., Bloch, MD MPH, K.C., Bhimraj, MD, A. (eds) Neurological Complications of Infectious Diseases. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-030-56084-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-56084-3_11

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-56083-6

  • Online ISBN: 978-3-030-56084-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation